Varenicline .5 mg Tablet, Film Coated, 56-count
by Zydus Lifesciences Limited · 56 TABLET, FILM COATED in 1 BOTTLE (70771-1773-6)
NDC 70771-1773-06
🏷️ FDA NDC (as labeled)
70771-1773-6
billing pads the package segment with a zero
Rx only
Generic
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
70771-1773-6
Product NDC
70771-1773
11-digit billing NDC
70771177306
UNII
82269ASB48
Application #
ANDA216723
SPL Set ID
481b94af-ee34-44be-8ca1-b2415525efac
Established class (EPC)
Cholinergic Receptor Agonist; Partial Cholinergic Nicotinic Agonist
Mechanism of action
Cholinergic Agonists; Partial Cholinergic Nicotinic Agonists
DEA schedule
Non-controlled
Marketing category
ANDA
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2023-06-13
Route
ORAL
Dosage form
TABLET, FILM COATED
Substance
VARENICLINE TARTRATE
TE code (Orange Book)
AB · RLD · RS
Why two NDCs?
The FDA registers this code as 70771-1773-6 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70771-1773-06. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Partial Cholinergic Nicotinic Agonist class.
Pharmacologic class
Partial Cholinergic Nicotinic Agonist, Cholinergic Receptor Agonist
Drug family (ATC)
Drugs used in nicotine dependence, Other ophthalmologicals
How it works
Cholinergic Agonists, Partial Cholinergic Nicotinic Agonists
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerZydus Lifesciences Limited
Application holderZYDUS WORLDWIDE DMCC
FDA applicationANDA216723 (ANDA)
Labeler code70771
First marketedJun 2023
Product typeHuman Prescription Drug
Portfolio717 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
📖 What it is MedlinePlus · NLM
Varenicline is used along with education and counseling to help people stop smoking. Varenicline is in a class of medications called smoking cessation aids. It works by blocking the pleasant effects of nicotine (from smoking) on the brain.
Read the full MedlinePlus article ↗📗 Our plain-language guide HelloPharmacist
- They both contain varenicline, but they are completely different products used for completely different things. Chantix and the generic tablets are taken by mouth to help you quit...
- What's the difference between Chantix (or the generic tablets) and Tyrvaya? Are they the same thing?
- Nausea is the most common side effect, and it affects a real number of people, but the good news is it's usually mild to moderate and often improves as your body adjusts. Starting...
- Nausea sounds rough — is it going to be bad the whole time I'm on the tablets?
Patient education
Supplement & herbal interactions
Some supplements/herbs that may interact with Varenicline — tap one for details:
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about Varenicline?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
💊 What it looks like
Color
White / Blue
ShapeCapsule
ImprintZV2
Size1 mm
ScoringNot scored
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII L11K75P92J
A mineral salt made from calcium and phosphate. It acts as a filler and binder in tablets to add bulk and help hold the medicine together in solid form.
-
UNII OP1R32D61U
Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
-
UNII M28OL1HH48
Croscarmellose sodium is a plant-based substance derived from cellulose. It acts as a disintegrant, helping tablets and capsules break down quickly in the digestive system so the medicine can be absorbed.
-
UNII 0VUT3PMY82
Hypromellose 2910 is a plant-derived thickening agent made from cellulose. In medicines, it forms protective coatings on tablets or capsules, controls how fast the drug releases, and thickens liquid formulations.
-
UNII 0WZ8WG20P6
Hypromellose 2910 is a plant-based cellulose derivative that acts as a thickener, binder, and film-coating agent. It helps control how quickly the medicine dissolves and protects the tablet or capsule from moisture and light.
-
UNII 70097M6I30
Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
-
UNII ETJ7Z6XBU4
Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
-
UNII 15FIX9V2JP
Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
-
UNII XHX3C3X673
Triacetin is a clear, oily liquid made from glycerin and acetic acid. It works as a plasticizer and solvent in medicines, helping soften coatings and improve how liquids mix together in formulations.
9 inactive ingredients listed in the exact product block matched to this NDC.
Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed —
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per each | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · Q2 2026 | $1.45 | $81.30 / 56 tablets |
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| varenicline .5 mg 00904-7413-35 | Major | 56 tablets | $0.312 | AB | Availability likely | — |
| Varenicline .5 mg 27241-0173-56 | Ajanta | 56 tablets | $0.312 | AB | Availability likely | — |
| Varenicline .5 mg 31722-0678-56 | Camber | 56 tablets | $0.312 | AB | Availability likely | — |
| Varenicline .5 mg 33342-0489-19 | Macleods | 56 tablets | $0.312 | AB | Availability likely | — |
| varenicline tartrate .5 mg 43598-0907-56 | Dr. | 56 tablets | $0.312 | AB | Availability likely | — |
| Varenicline .5 mg 49884-0155-76 | Par | 56 tablets | $0.312 | AB | Availability likely | — |
| Varenicline .5 mg 59651-0417-56 | Aurobindo | 56 tablets | $0.312 | AB | Availability likely | — |
| Varenicline .5 mg 60505-3613-05 | Apotex | 56 tablets | $0.312 | AB | Availability likely | — |
| varenicline .5 mg 67877-0743-95 | Ascend | 56 tablets | $0.312 | AB | Availability likely | — |
| varenicline tartrate .5 mg 68462-0893-56 | Glenmark | 56 tablets | $0.312 | AB | Availability likely | — |
| Varenicline .5 mg 70710-1613-06 | Zydus | 56 tablets | $0.312 | AB | Availability likely | — |
| Varenicline .5 mg 70748-0127-49 | Lupin | 56 tablets | $0.312 | AB | Availability likely | — |
| Varenicline tartrate .5 mg 71921-0308-56 | Florida | 56 tablets | $0.312 | AB | Availability likely | — |
| Varenicline .5 mg 72603-0476-01 | NorthStar | 56 tablets | $0.312 | AB | Availability likely | — |
| Varenicline Tartrate .5 mg/561 69315-0402-56 | Leading | 56 tablets | $0.337 | AB | Availability likely | — |
| Chantix .5 mg 00069-0468-56 | Pfizer | 56 tablets | $7.852 | AB | FDA listed | — |
| Varenicline .5 mg 10135-0808-56 | Marlex | 56 tablets | — | AB | FDA listed | — |
| Varenicline tartrate .5 mg 14445-0153-56 | Indoco | 56 tablets | — | AB | FDA listed | — |
| varenicline .5 mg 42291-0927-56 | AvKARE | 56 tablets | — | AB | FDA listed | — |
| varenicline tartrate .5 mg 42571-0459-82 | Micro | 56 tablets | — | AB | FDA listed | — |
| Varenicline .5 mg 50090-6447-00 | A-S | 56 tablets | — | AB | FDA listed | — |
| varenicline .5 mg 50090-7135-00 | A-S | 56 tablets | — | AB | FDA listed | — |
| Varenicline tartrate .5 mg 50090-7996-00 | A-S | 56 tablets | — | AB | FDA listed | — |
| Varenicline .5 mg 51407-0755-56 | Golden | 56 tablets | — | AB | FDA listed | — |
| Varenicline .5 mg 60290-0077-01 | Umedica | 56 tablets | — | AB | FDA listed | — |
| Varenicline .5 mg 70518-4647-00 | REMEDYREPACK | 1 tablet | — | AB | FDA listed | — |
| Varenicline .5 mgthis 70771-1773-06 | Zydus | 56 tablets | — | AB | FDA listed | — |
| Varenicline .5 mg 72162-2218-02 | Bryant | 56 tablets | — | AB | FDA listed | — |
| varenicline .5 mg 75834-0334-28 | Nivagen | 56 tablets | — | AB | FDA listed | — |
| Varenicline Tartrate .5 mg/561 85742-0015-15 | Kanchan | 56 tablets | — | AB | FDA listed | — |
| Varenicline .5 mg 50090-8088-00 | A-S | 1 tablet | — | AB | FDA listed | — |
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2023
On the market since
Jun 2023
📍
2026
Currently FDA-listed
3 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Varenicline — the ingredient across all brands.
Top reported reactions
Age at onset
Reporter sex
Male · 35%
Female · 64%
Unknown · 1%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 70771-1773-06 You're viewing this | 56 TABLET, FILM COATED in 1 BOTTLE (70771-1773-6) | 2023-06-13 | Active |
🧭 About this NDC listing & data coverage
Finished prescription product
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | ✓ Available |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 70771-1773-6, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 70771-1773-06, written without dashes as 70771177306. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 70771-1773-06, the first segment (70771) is the labeler code FDA assigned to Zydus Lifesciences Limited; the middle segment (1773) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (06) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Zydus Lifesciences Limited. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Zydus Lifesciences Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 Full prescribing information FDA SPL
The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
💬 Medication Guide ▾
SPL MEDGUIDE
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.